Rigel Pharmaceuticals

- rigel.com

Rigel Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on the discovery and development of novel, small-molecule drugs for the treatment of immune diseases and cancers.

2,663,576 $ 480.00

Advanced NS NSCLC Treatment | ALIMTA® (pemetrexed for injection)

- alimta.com

Learn how ALIMTA may help treat advanced nonsquamous non-small cell lung cancer. Find information about ALIMTA and platinum chemotherapy (carboplatin or cisplatin) in combination with KEYTRUDA® (pembrolizumab).

5,628,921 $ 240.00

Vicus Therapeutics - Bringing Breakthrough Combination Immunotherapies

- vicustherapeutics.com

Vicus Therapeutics brings breakthrough and low cost adjunct therapies to patients with cancer

23,338,727 $ 8.95

IRESSA® (gefitinib) | Information and resources

- medicationforlungcancer.com

Learn about IRESSA (gefitinib), now approved for first-line treatment of EGFR mutation–positive patients with metastatic NSCLC

Not Applicable $ 8.95

Healthcare Professional Site | OPDIVO® (nivolumab)

- pd-l1test.com

Learn about OPDIVO® for patients with Previously Treated Metastatic Squamous and Non-Squamous Non-Small Cell Lung Cancer (NSCLC). Please see Indication and Important Safety Information.

Not Applicable $ 8.95

First-line Treatment of Metastatic Squamous Non-Small Cell Lung Cancer

- treatmentoptionformetassqnsclc.com

Portrazza in combination with gemcitabine and cisplatin, is the first approved biologic for the treatment of patients who are chemo-naive for their metastatic non-small cell lung cancer.

Not Applicable $ 8.95

The Best Oncologist TM

- thebestoncologist.com

The site gives information about cancer, cancer treatment, cancer drugs, links to oncology journals, links to oncology sites, information about cancer related conferences, both in english and Arabic

7,565,786 $ 240.00

Lipoplatin™ Global

- sermovacka.sk

Chemotherapy Drug: Liposomal Cisplatin Suspension for Injection by Regulon

Not Applicable $ 8.95

Home | Living With ALK

- alunbrig.net

Empower yourself or a loved one with ALK+ lung cancer through helpful information on living with ALK from treatment options to lifestyle tips

Not Applicable $ 8.95

OPDIVO® (nivolumab) | Patient Gateway

- opdivo.site

OPDIVO® (nivolumab) is a prescription medication. Read about its indications, side effects, and more.

Not Applicable $ 8.95

Rigel Pharmaceuticals

- rigel.help

Rigel Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on the discovery and development of novel, small-molecule drugs for the treatment of immune diseases and cancers.

Not Applicable $ 8.95

ATEZOLIZUMAB | ROCHE

- rochesafetytool.com

ROCHE provides information for healthcare professionals who are prescribing Atezolizumab

Not Applicable $ 8.95